← FDA Drug Approvals (Drugs@FDA)

ARIPIPRAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2026-02-18

Drug application

FDA Application #

ANDA216208

Application type

Abbreviated New Drug Application (Generic)

Brand name

ARIPIPRAZOLE

Generic name

ARIPIPRAZOLE

Active ingredients

ARIPIPRAZOLE

Dosage form

TABLET, ORALLY DISINTEGRATING

Route

ORAL

Marketing status

Prescription

Sponsor

AUROBINDO PHARMA

Manufacturer

Aurobindo Pharma Limited

First approval

2026-02-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown